Lang Matthew — SEC Form 4 filings

SEC reporting owner CIK 1712069. 5 Form 4 filings on record with FilingPulse; latest filed 2026-04-23.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-02-13 to 2026-04-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Lyell Immunopharma, Inc. (LYEL)Chief Business Officer25
Metsera, Inc. (MTSR)CHIEF LEGAL OFFICER25
Structure Therapeutics Inc. (GPCR)COO & GC12

Form 4 filings — Lang Matthew

FiledFormIssuerReported transactionsSource
2026-04-234Structure Therapeutics Inc. (GPCR)Grant/award (A): 184,614 @ $0 · Grant/award (A): 223,776 (derivative) @ $0EDGAR
2025-11-134Metsera, Inc. (MTSR)Disposition to issuer (D): 12,500 · Grant/award (A): 12,500 (derivative) · Disposition to issuer (D): 46,875 (derivative) · Disposition to issuer (D): 325,000 (derivative)EDGAR
2025-05-224Metsera, Inc. (MTSR)Grant/award (A): 46,875 (derivative) @ $0EDGAR
2025-02-264Lyell Immunopharma, Inc. (LYEL)Grant/award (A): 112,500 @ $0 · Grant/award (A): 450,000 (derivative) @ $0 · Grant/award (A): 56,250 (derivative) @ $0EDGAR
2024-02-134Lyell Immunopharma, Inc. (LYEL)Grant/award (A): 50,000 @ $0 · Grant/award (A): 500,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1712069 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →